Anemia

Anemia / 2017 / Article / Tab 1

Research Article

Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia

Table 1

Demographic and baseline characteristics (safety population).

FCM
()
SMC
()

Demographic characteristics
Mean (SD) age, years31.2 (9.36)31.4 (8.98)
Race, (%)
 White457 (45.9)477 (46.7)
 African American391 (39.3)387 (37.9)
 Hispanic122 (12.2)135 (13.2)
 Asian5 (0.5)8 (0.8)
 Other21 (2.1)15 (1.5)
Mean (SD) height, cm163.4 (6.93)163.1 (7.07)
Mean (SD) weight, kg82.0 (21.71)82.8 (21.64)
Mean (SD) prepregnancy weight, kg72.4 (19.96)73.3 (19.85)
Baseline characteristics
Etiology of anemia, (%)
 Postpartum606 (60.8)623 (61.0)
 Heavy menstrual bleeding390 (39.2)399 (39.0)
Cardiac risk factor, (%)
 Low709 (71.2)723 (70.7)
 High287 (28.8)299 (29.3)
Poor response to oral iron, (%)
 Yes236 (43.1)252 (44.4)
 No312 (56.9)316 (55.6)
Mean (SD) hemoglobin, g/dL9.9 (1.32)9.8 (1.29)

FCM = ferric carboxymaltose; SD = standard deviation; SMC = standard medical care.
for ferric carboxymaltose and for standard medical care.
for ferric carboxymaltose and for standard medical care.
Prepregnancy weight for postpartum subjects only; for ferric carboxymaltose and for standard medical care.
If a subject had ≤1 cardiac risk factor (specifically, smoking, high blood pressure, high blood cholesterol, diabetes, overweight or obese, physical inactivity, or family history of heart disease), the subject was categorized as low cardiac risk; if the subject had ≥2 risk factors, they were categorized as high cardiac risk.
for ferric carboxymaltose and for standard medical care.
for ferric carboxymaltose and for standard medical care.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.